Moving Us Forward

This session explores the groundbreaking use of optical genome mapping (OGM) in identifying and understanding hematologic malignancies. Dr. Susan Crocker will focus on how OGM aids in the analysis of Acute Myeloid Leukemia (AML), presenting case studies where VIA interpretation software provides comprehensive genomic profiles. Dr. Tracy Tucker will present on OGM’s effectiveness in detecting genetic abnormalities in Chronic Lymphocytic Leukemia (CLL), highlighting advantages over traditional methods and the impact of findings. Additionally, Dr. Gokce Toruner will share extensive clinical research, detailing results from over 500 hematologic malignancy samples that utilized OGM for better genetic insights. The session will close with a Q&A session led by Dr. Alex Hastie, Vice President of Clinical and Scientific Affairs at Bionano.

This session will focus on optical genome mapping (OGM) in solid tumor research. Dr. Ying Zhou will discuss the use of OGM in sarcoma research, she will highlight the advantages of OGM in identifying variations crucial for understanding sarcoma. Dr. Shiva Sathyanarayana will explore the application of OGM in lymphoma research, focusing on how OGM enhances the detection of genetic anomalies in lymphomas, providing improvements over traditional methods and more accurate understanding. Dr. Dan Ackerman will share his clinical research on the use of OGM in brain and liver tumors, demonstrating how OGM can reveal hidden genetic alterations and structural variants that are crucial for understanding complex tumors. The session will conclude with a Q&A session moderated by Alex Hastie, VP of clinical affairs.

Join this session to experience the latest advancements in Bionano’s optical genome mapping (OGM) Stratysphere workflow, now enhanced with streamlined sample preparation and advanced structural variant (SV) databasing analysis. Alex Hastie, will kick off with an overview of the workflow, previewing the Ionic® system’s role in automating sample prep. Alex will also familiarize you with the features of our high-throughput OGM system, Stratys. Jenna Finley, will then cover the latest features of VIA™, Bionano’s advanced data analysis software. Jenna will present case studies demonstrating how the Stratysphere workflow can reduce turnaround times, increase throughput, and improve the precision of detecting structural and numerical variants. Don’t miss this chance to explore how the Stratysphere workflow, can elevate your lab’s capabilities in transforming the future of cytogenomics.